Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
$THRD (Third Harmonic Bio) stole the spotlight with a massive 39.84% jump after announcing plans to liquidate the company. liquidation typically sends investors fleeing — but in this case, it sparked a surge. why? the company is returning capital to shareholders, and the market believes the wind-down could unlock hidden value. in addition, its plans to offload its urticaria treatment program THB335 added clarity. over 14 million shares traded — an eye-popping spike against its average, confirming the bullish sentiment among traders looking for exit windfalls.
$BETR (Better Home & Finance) climbed 20.62% on news it’s retiring $530M in convertible notes. this kind of financial cleanup tells investors the company is getting leaner and possibly steering toward profitability. that level of debt reduction can shift sentiment fast, and that's exactly what we saw — a sharp break above recent resistance with a big volume confirmation.
$TUSK (Mammoth Energy) surged 20.11% after announcing a $108M deal to sell off its infrastructure units. plus, its ceo is stepping down — a classic market-friendly combo when investors are hungry for strategic direction. the spike signals traders are betting on a leaner, more focused company going forward. technically, the breakout from a consolidation base suggests the rally might have legs.
$NB (NioCorp Developments) tacked on 18.45% thanks to broad sector strength in metals & mining, particularly rare earths. paired with tailwinds from an upbeat market session and rising interest in strategic materials, $NB surged on volume that dwarfed its daily average. this name is trending strong, aided by macro themes like onshoring and EV-related demand.
$SUPV (Grupo Supervielle) and $BMA (Banco Macro) — two Argentine financial players — moved sharply higher, up 17.8% and 15.41% respectively. argentina’s central bank shift and ETF inflows into ARGT (Global X MSCI Argentina ETF) fueled this rally. international investors appear to be warming up to the idea of macro reform progress in the region, and these banks are among the first to benefit.
$ECX (ECARX) jumped 13.68% on the back of a flashy product announcement. the company unveiled ECARXperience, its adaptive AI-powered in-vehicle interface. traders love innovation, especially when it connects to buzzwords like AI and mobility — and ECARX checked both boxes. the 3x surge in volume confirmed that momentum traders were onboard.
$CARA (Cara Therapeutics) added 13.26% after announcing a 1-for-3 reverse split ahead of a merger with Tvardi Therapeutics. reverse splits aren’t always a good thing, but in this case, the move is seen as preparation for a stronger combined entity. it’s a sign of transition, and Monday's action suggests the market liked what it saw.
$SMMT (Summit Therapeutics) gained 12.44%, driven by continued bullish sentiment around its lead pipeline drug. renewed analyst support and investor confidence are helping push this biotech name higher, particularly as traders rotate into companies with strong R&D potential and high conviction backing.
$CERT (Certara) rallied 11.54% after unveiling better-than-expected Q1 sales projections and announcing a $100M buyback plan. this one-two punch of earnings strength and shareholder-friendly action lit a fire under the stock, with volume surging more than 3x. the chart broke out cleanly above its recent range — a classic sign of institutional accumulation.
finally, $VKTX (Viking Therapeutics) closed up 10.58% following Pfizer’s announcement that it’s scrapping development of a rival obesity drug due to safety concerns. that leaves more room for players like Viking to run. add in strong sentiment around obesity treatments (thanks to the ongoing success of Novo Nordisk and Eli Lilly), and you’ve got a cocktail for a momentum breakout.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.